Nuclear Medicine Our Product Portfolio

Discover our portfolio of radiodiagnostics and therapeutic — designed to support better outcomes for patients worldwide.

01
Supporting the diagnosis and management of cardiovascular diseases.
02
Advancing nuclear medicine solutions for endocrine and metabolic disorders.
03
Supporting the evaluation of gastrointestinal function and disease through precision imaging.
04
Providing nuclear medicine solutions for blood disorders and related cancers.
05
Helping detect and monitor infection and inflammatory disease with precision imaging.
06
Supporting liver and spleen imaging with specialised nuclear medicine solutions.
07
Advancing lymphatic imaging solutions for disease staging and treatment planning.
08
Enhancing the detection and monitoring of bone and joint conditions.
09
Supporting renal imaging and kidney function assessment through nuclear medicine.
10
Advancing brain imaging solutions for neurological disorders and diseases.
11
Delivering precision nuclear medicine solutions for cancer diagnosis and treatment.
12
Supporting lung imaging and respiratory assessment with advanced nuclear medicine solutions.
13
Providing reliable radionuclide generator technologies for diagnostic isotope production.
14
Supporting the diagnosis and treatment of rare diseases through specialised nuclear medicine solutions.
15
Supporting the evaluation of inflammatory and autoimmune musculoskeletal disorders.
16
Providing nuclear medicine solutions for the diagnosis and management of urological conditions.

Selected

Disease Area

Cardiology
Endocrinology
Gastroenterology
Hematology
Infectious Diseases
Liver & Spleen
Lymphology
Musculoskeletal
Nephrology
Neurology
Oncology
Pulmonology
Radionuclide Generators
Rare Diseases
Rheumatology
Urology

Product Type

Therapeutic
PET
SPECT
Active Ingredient
Medical Device

Manufacturing Site

Maryland Heights
Petten
Saclay
Gebze

Market

All products A-Z

ERtracER

ERtracER Solution for Injection

Active ingredient

F18-fludeoxyglucose

Disease area

Cardiology, Infectious Diseases, Neurology, Oncology

Available in
, 

ERtracER in International

Product information
, 

ERtracER in Ireland

Product information

ERtracER in United Kingdom

Product information

Fludeomap

Fludeomap 250 MBq/ml solution for injection

Active ingredient

F18-fludeoxyglucose

Disease area

Cardiology, Infectious Diseases, Neurology, Oncology

Available in
, 

Fludeomap in Estonia

Product information
, 

Fludeomap in Finland

Product information
, 

Fludeomap in Latvia

Product information
, 

Fludeomap in Lithuania

Product information
, 

Fludeomap in Norway

Product information

Fludeomap in Sweden

Product information

Fludeoxyglucose (18F)-Curium

Fludeoxyglucose (18F)-Curium 185 MBq/mL solution for injection

Active ingredient

F18-fludesoxyglucose

Disease area

Cardiology, Infectious Diseases, Neurology, Oncology

Available in
, 

Fludeoxyglucose (18F)-Curium in Austria

Product information
, 

Fludeoxyglucose (18F)-Curium in Belgium

Product information
, 

Fludeoxyglucose (18F)-Curium in France

Product information
, 

Fludeoxyglucose (18F)-Curium in International

Product information
, 

Fludeoxyglucose (18F)-Curium in Italy

Product information
, 

Fludeoxyglucose (18F)-Curium in Luxembourg

Product information
, 

Fludeoxyglucose (18F)-Curium in Malta

Product information
, 

Fludeoxyglucose (18F)-Curium in Netherlands

Product information
, 

Fludeoxyglucose (18F)-Curium in Portugal

Product information
, 

Fludeoxyglucose (18F)-Curium in Slovenia

Product information

Fludeoxyglucose (18F)-Curium in Spain

Product information

Fludeoxyglucose (18F)

Fludeoxyglucose (18F) Monrol 200-2200 MBq/ml solution for injection

Active ingredient

F18-fludeoxyglucose

Disease area

Cardiology, Infectious Diseases, Neurology, Oncology

Available in
, 

Fludeoxyglucose (18F) in Bulgaria

Product information
, 

Fludeoxyglucose (18F) in Greece

Product information

Fludeoxyglucose (18F) in Romania

Product information

GlucoTep

GlucoTep 150 MBq/mL solution for injection

Active ingredient

F18-fludesoxyglucose

Disease area

Cardiology, Infectious Diseases, Neurology, Oncology

Available in

GlucoTep in France

Product information

Kit for the Preparation of Technetium Tc99m Sestamibi Injection

Tc 99m Sestamibi Injection

Active ingredient

Cu MIBI

Disease area

Cardiology, Oncology

Available in
, 

Kit for the Preparation of Technetium Tc99m Sestamibi Injection in Canada

Product information

Kit for the Preparation of Technetium Tc99m Sestamibi Injection in United States

Product information

Stamicis®

Stamicis 1 mg kit for radiopharmaceutical preparation

Active ingredient

[tetrakis (2-methoxyisobutyl isonitrile) copper (I)] tetrafluoroborate (sestamibi)

Disease area

Cardiology

Available in
, 

Stamicis® in Australia

Product information
, 

Stamicis® in Austria

Product information
, 

Stamicis® in Belgium

Product information
, 

Stamicis® in Colombia

Product information
, 

Stamicis® in Czech Republic

Product information
, 

Stamicis® in Denmark

Product information
, 

Stamicis® in Finland

Product information
, 

Stamicis® in France

Product information
, 

Stamicis® in Germany

Product information
, 

Stamicis® in Greece

Product information
, 

Stamicis® in India

Product information
, 

Stamicis® in International

Product information
, 

Stamicis® in Ireland

Product information
, 

Stamicis® in Israel

Product information
, 

Stamicis® in Italy

Product information
, 

Stamicis® in Luxembourg

Product information
, 

Stamicis® in Netherlands

Product information
, 

Stamicis® in Norway

Product information
, 

Stamicis® in Peru

Product information
, 

Stamicis® in Portugal

Product information
, 

Stamicis® in Republic of Korea

Product information
, 

Stamicis® in Singapore

Product information
, 

Stamicis® in Slovakia

Product information
, 

Stamicis® in Slovenia

Product information
, 

Stamicis® in Spain

Product information
, 

Stamicis® in Sweden

Product information
, 

Stamicis® in Switzerland

Product information

Stamicis® in United Kingdom

Product information

Teceos®

Teceos 13 mg kit for radiopharmaceutical preparation

Active ingredient

Butedronate tetrasodium

Disease area

Cardiology, Oncology

Available in
, 

Teceos® in Austria

Product information
, 

Teceos® in Denmark

Product information
, 

Teceos® in Finland

Product information
, 

Teceos® in France

Product information
, 

Teceos® in Germany

Product information
, 

Teceos® in Greece

Product information
, 

Teceos® in International

Product information
, 

Teceos® in Mexico

Product information
, 

Teceos® in Netherlands

Product information
, 

Teceos® in Norway

Product information
, 

Teceos® in Republic of Korea

Product information
, 

Teceos® in Spain

Product information
, 

Teceos® in Sweden

Product information

Teceos® in Switzerland

Product information

Technescan™ PYP

Technescan PYP 20 mg kit for radiopharmaceutical preparation

Active ingredient

Sodium pyrophosphate

Disease area

Cardiology, Gastroenterology, Hematology

Available in
, 

Technescan™ PYP in Belgium

Product information
, 

Technescan™ PYP in Colombia

Product information
, 

Technescan™ PYP in Costa Rica

Product information
, 

Technescan™ PYP in Czech Republic

Product information
, 

Technescan™ PYP in Denmark

Product information
, 

Technescan™ PYP in Finland

Product information
, 

Technescan™ PYP in France

Product information
, 

Technescan™ PYP in Germany

Product information
, 

Technescan™ PYP in Hungary

Product information
, 

Technescan™ PYP in Ireland

Product information
, 

Technescan™ PYP in Italy

Product information
, 

Technescan™ PYP in Malaysia

Product information
, 

Technescan™ PYP in Mexico

Product information
, 

Technescan™ PYP in Netherlands

Product information
, 

Technescan™ PYP in Norway

Product information
, 

Technescan™ PYP in Peru

Product information
, 

Technescan™ PYP in Republic of Korea

Product information
, 

Technescan™ PYP in Romania

Product information
, 

Technescan™ PYP in Singapore

Product information
, 

Technescan™ PYP in Spain

Product information
, 

Technescan™ PYP in Sweden

Product information
, 

Technescan™ PYP in Turkey

Product information

Technescan™ PYP in United Kingdom

Product information

Technescan™ PYP™

(kit for the preparation of technetium Tc 99m pyrophosphate injection)

Active ingredient

Tc99m-pyrophosphate

Disease area

Cardiology, Gastroenterology, Hematology, Musculoskeletal

Available in
, 

Technescan™ PYP™ in Australia

Product information

Technescan™ PYP™ in United States

Product information

Technescan™ Sestamibi

Technescan Sestamibi 1 mg kit for radiopharmaceutical preparation

Active ingredient

[Tetrakis (2-methoxy-2-methylpropyl-1 isocyanide)copper(I)] tetrafluoroborate

Disease area

Cardiology, Endocrinology, Oncology

Available in
, 

Technescan™ Sestamibi in Austria

Product information
, 

Technescan™ Sestamibi in Belgium

Product information
, 

Technescan™ Sestamibi in Bulgaria

Product information
, 

Technescan™ Sestamibi in Cyprus

Product information
, 

Technescan™ Sestamibi in Czech Republic

Product information
, 

Technescan™ Sestamibi in Denmark

Product information
, 

Technescan™ Sestamibi in Estonia

Product information
, 

Technescan™ Sestamibi in Finland

Product information
, 

Technescan™ Sestamibi in France

Product information
, 

Technescan™ Sestamibi in Germany

Product information
, 

Technescan™ Sestamibi in Greece

Product information
, 

Technescan™ Sestamibi in Hungary

Product information
, 

Technescan™ Sestamibi in International

Product information
, 

Technescan™ Sestamibi in Ireland

Product information
, 

Technescan™ Sestamibi in Italy

Product information
, 

Technescan™ Sestamibi in Latvia

Product information
, 

Technescan™ Sestamibi in Lithuania

Product information
, 

Technescan™ Sestamibi in Luxembourg

Product information
, 

Technescan™ Sestamibi in Netherlands

Product information
, 

Technescan™ Sestamibi in Norway

Product information
, 

Technescan™ Sestamibi in Portugal

Product information
, 

Technescan™ Sestamibi in Romania

Product information
, 

Technescan™ Sestamibi in Slovakia

Product information
, 

Technescan™ Sestamibi in Slovenia

Product information
, 

Technescan™ Sestamibi in Spain

Product information
, 

Technescan™ Sestamibi in Sweden

Product information
, 

Technescan™ Sestamibi in Switzerland

Product information

Technescan™ Sestamibi in United Kingdom

Product information

Thallium 201TI

Thallium (201Tl) chloride CIS bio international 37 MBq/mL solution for injection (Tl-201-S-1)

Active ingredient

Tl201-chloride

Disease area

Cardiology, Endocrinology, Musculoskeletal, Oncology

Available in
, 

Thallium 201TI in Austria

Product information
, 

Thallium 201TI in Belgium

Product information
, 

Thallium 201TI in France

Product information
, 

Thallium 201TI in Greece

Product information
, 

Thallium 201TI in International

Product information
, 

Thallium 201TI in Luxembourg

Product information
, 

Thallium 201TI in Mexico

Product information
, 

Thallium 201TI in Netherlands

Product information
, 

Thallium 201TI in Portugal

Product information
, 

Thallium 201TI in South America

Product information
, 

Thallium 201TI in Spain

Product information

Thallium 201TI in Taiwan

Product information

Thallous Chloride Tl 201 Injection

Thallous Chloride Tl 201 Injection

Active ingredient

Tl201-Chloride

Disease area

Cardiology, Endocrinology

Available in
, 

Thallous Chloride Tl 201 Injection in Austria

Product information
, 

Thallous Chloride Tl 201 Injection in Belgium

Product information
, 

Thallous Chloride Tl 201 Injection in Czech Republic

Product information
, 

Thallous Chloride Tl 201 Injection in Denmark

Product information
, 

Thallous Chloride Tl 201 Injection in Finland

Product information
, 

Thallous Chloride Tl 201 Injection in France

Product information
, 

Thallous Chloride Tl 201 Injection in Germany

Product information
, 

Thallous Chloride Tl 201 Injection in Hungary

Product information
, 

Thallous Chloride Tl 201 Injection in Ireland

Product information
, 

Thallous Chloride Tl 201 Injection in Italy

Product information
, 

Thallous Chloride Tl 201 Injection in Netherlands

Product information
, 

Thallous Chloride Tl 201 Injection in Portugal

Product information
, 

Thallous Chloride Tl 201 Injection in Singapore

Product information
, 

Thallous Chloride Tl 201 Injection in Slovakia

Product information
, 

Thallous Chloride Tl 201 Injection in Spain

Product information
, 

Thallous Chloride Tl 201 Injection in Sweden

Product information
, 

Thallous Chloride Tl 201 Injection in Switzerland

Product information
, 

Thallous Chloride Tl 201 Injection in United Kingdom

Product information

Thallous Chloride Tl 201 Injection in United States

Product information

Ultratag™ RBC

(Kit for the Preparation of Technetium Tc 99m Red Blood Cells Injection)

Active ingredient

N/A

Disease area

Cardiology, Gastroenterology, Hematology

Available in
, 

Ultratag™ RBC in Czech Republic

Product information
, 

Ultratag™ RBC in Denmark

Product information
, 

Ultratag™ RBC in Hungary

Product information
, 

Ultratag™ RBC in Netherlands

Product information

Ultratag™ RBC in Slovakia

Product information

Ultratag™ RBC

(Kit for the Preparation of Technetium Tc 99m Red Blood Cells Injection)

Active ingredient

N/A

Disease area

Cardiology, Gastroenterology, Hematology

Available in
, 

Ultratag™ RBC in Australia

Product information

Ultratag™ RBC in United States

Product information

Vasculocis®

Vasculocis 10 mg kit for radiopharmaceutical preparation

Active ingredient

human serum albumin

Disease area

Cardiology

Available in
, 
, 

Vasculocis® in Denmark

Product information
, 

Vasculocis® in Finland

Product information
, 

Vasculocis® in France

Product information
, 

Vasculocis® in International

Product information
, 

Vasculocis® in Luxembourg

Product information
, 

Vasculocis® in Netherlands

Product information

Vasculocis® in Sweden

Product information